He X, Zai G, Zhou L, Chen S, Wang G
J Inflamm Res. 2024; 17:1671-1683.
PMID: 38504696
PMC: 10948335.
DOI: 10.2147/JIR.S452505.
Chen D, Zhou W, Chen J, Wang J
Aging (Albany NY). 2023; 15(24):15504-15524.
PMID: 38157278
PMC: 10781469.
DOI: 10.18632/aging.205389.
Cartwright T, Harris R, Meyer S, Mon A, Watson N, Tan C
Sci Rep. 2022; 12(1):11210.
PMID: 35778595
PMC: 9249732.
DOI: 10.1038/s41598-022-15339-8.
Wu J, Li T, Ji H, Chen Z, Zhai B
Front Pharmacol. 2022; 13:874235.
PMID: 35559251
PMC: 9086458.
DOI: 10.3389/fphar.2022.874235.
Linville A, Rico A, Teague H, Binsted L, Smith G, Albarnaz J
J Virol. 2022; 96(11):e0039822.
PMID: 35543552
PMC: 9175622.
DOI: 10.1128/jvi.00398-22.
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation.
Colmenero-Repiso A, Gomez-Munoz M, Rodriguez-Prieto I, Amador-Alvarez A, Henrich K, Pascual-Vaca D
Cancers (Basel). 2020; 12(11).
PMID: 33233777
PMC: 7699843.
DOI: 10.3390/cancers12113465.
VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage.
Garcia-Gonzalez R, Morejon-Garcia P, Campillo-Marcos I, Salzano M, Lazo P
Cancers (Basel). 2020; 12(10).
PMID: 33076429
PMC: 7650776.
DOI: 10.3390/cancers12102986.
Downregulation of VRK1 reduces the expression of BANF1 and suppresses the proliferative and migratory activity of esophageal cancer cells.
Ren Z, Geng J, Xiong C, Li X, Li Y, Li J
Oncol Lett. 2020; 20(2):1163-1170.
PMID: 32724356
PMC: 7377186.
DOI: 10.3892/ol.2020.11654.
Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.
Ngow Y, Rajan S, Ye H, Yoon H
Protein Sci. 2018; 28(3):524-532.
PMID: 30461091
PMC: 6371211.
DOI: 10.1002/pro.3552.
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?.
Campillo-Marcos I, Lazo P
Cell Mol Life Sci. 2018; 75(13):2375-2388.
PMID: 29679095
PMC: 5986855.
DOI: 10.1007/s00018-018-2811-2.
VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
Liu Z, Cao K, Xiao Z, Qiao L, Wang X, Shang B
Oncotarget. 2017; 8(39):65642-65658.
PMID: 29029460
PMC: 5630360.
DOI: 10.18632/oncotarget.20020.
Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.
Lee N, Kim D, Han S, Ryu H, Park S, Kim K
Mol Cells. 2017; 40(9):621-631.
PMID: 28927264
PMC: 5638770.
DOI: 10.14348/molcells.2017.0108.
Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation.
Moura D, Fernandez I, Marin-Royo G, Lopez-Sanchez I, Martin-Doncel E, Vega F
Sci Rep. 2016; 6:28532.
PMID: 27334688
PMC: 4917848.
DOI: 10.1038/srep28532.
Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.
Liu J, Wang Y, He S, Xu X, Huang Y, Tang J
Hematology. 2016; 21(10):603-612.
PMID: 27319807
PMC: 9491125.
DOI: 10.1080/10245332.2016.1147678.
Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
Lee N, Kwon J, Kim Y, Kim S, Park S, Xu W
Oncotarget. 2015; 6(30):30130-48.
PMID: 26375549
PMC: 4745786.
DOI: 10.18632/oncotarget.4967.
VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle.
Cantarero L, Sanz-Garcia M, Vinograd-Byk H, Renbaum P, Levy-Lahad E, Lazo P
Sci Rep. 2015; 5:10543.
PMID: 26068304
PMC: 4464288.
DOI: 10.1038/srep10543.
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.
Salzano M, Sanz-Garcia M, Monsalve D, Moura D, Lazo P
Epigenetics. 2015; 10(5):373-83.
PMID: 25923214
PMC: 4623420.
DOI: 10.1080/15592294.2015.1028708.
Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1.
Kim Y, Kim S, Shin J, Harikishore A, Lim J, Jung Y
PLoS One. 2014; 9(10):e109655.
PMID: 25310002
PMC: 4195671.
DOI: 10.1371/journal.pone.0109655.
Modulation of the chromatin phosphoproteome by the Haspin protein kinase.
Maiolica A, de Medina-Redondo M, Schoof E, Chaikuad A, Villa F, Gatti M
Mol Cell Proteomics. 2014; 13(7):1724-40.
PMID: 24732914
PMC: 4083111.
DOI: 10.1074/mcp.M113.034819.
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.
Salzano M, Vazquez-Cedeira M, Sanz-Garcia M, Valbuena A, Blanco S, Fernandez I
Oncotarget. 2014; 5(7):1770-8.
PMID: 24731990
PMC: 4039124.
DOI: 10.18632/oncotarget.1678.